There isn't really a "better" option between the two that's the honest answer most oncologists give when this question comes up. Chemotherapy vs immunotherapy in India is less a competition and more a matter of fit. Chemotherapy goes after cancer cells directly. Immunotherapy takes a different route entirely, working through the immune system to teach the body to recognise cancer on its own. Which treatment a patient ends up on or whether they get both depends on the cancer type, its stage, and a fair amount of testing before anything gets decided. 

How Chemotherapy Actually Works 

Chemotherapy drugs target cells that divide quickly, which is precisely what cancer cells tend to do. The catch is that some healthy cells divide fast too hair follicles, the lining of the gut, and bone marrow, which is why hair loss, nausea, and dips in blood counts show up so often during treatment. Chemotherapy has been the backbone of cancer care for decades, and for many cancers, it still is. Chemotherapy treatment in India is usually given in cycles, spaced out so the body gets time to recover between doses. 

How Immunotherapy Works 

Immunotherapy takes a longer path to reach the same goal. Rather than attacking cancer cells head-on, it works on the immune system, stripping away whatever "cloak" the cancer's been using to avoid detection, or simply giving immune cells the boost they need to do their job properly. When it works, the effects can last well beyond the treatment period itself, since the immune system essentially keeps watching afterward. When it doesn't work for a particular patient, though, there's often no in-between the response tends to be more binary than what you'd see with chemotherapy. 

Difference Between Chemotherapy and Immunotherapy: The Practical Side 

The main difference between chemotherapy and immunotherapy is what they target and how the body responds: 

• Chemotherapy kills cancer cells directly; immunotherapy activates the immune system to do that job instead 

• Chemotherapy's side effects tend to follow a predictable pattern: nausea, fatigue, and hair loss, while immunotherapy's side effects are less predictable and tied to immune activity, sometimes showing up in organs far from the tumour itself 

• Chemotherapy generally acts faster; immunotherapy responses can take longer to build 

• Chemotherapy is broadly applicable across many cancer types; immunotherapy depends heavily on whether specific biomarkers are present 

Neither list makes one option automatically better than the other. They're simply different tools, and the right one depends entirely on what's actually happening inside a specific patient's body. 

Which Cancers Respond Better to Each 

Chemotherapy remains the primary treatment for many cancers, especially ones where fast-growing cells dominate the picture certain blood cancers and several solid tumours respond well to it. Immunotherapy has shown particularly strong results in cancers like melanoma, some lung cancers, and select blood cancers, but mainly in patients whose tumours carry the right biomarkers. There are also cancers where neither works well alone, and that's often where combination approaches are used. 

Medical Oncology and Deciding Between the Two 

This choice isn't a decision made off a general rule of thumb. A medical oncology specialist in India typically looks at the cancer's stage, its genetic and biomarker profile, how it's responded to any prior treatment, and the patient's general health before recommending a path forward. Testing plays a bigger role here than most people expect a single biomarker result can shift the entire treatment plan from chemotherapy toward immunotherapy, or the other way around entirely. 

Can the Two Be Combined? 

Often, yes. It's becoming increasingly common for chemotherapy and immunotherapy to be used together, particularly for cancers where research supports the combination. Chemotherapy can shrink a tumour and sometimes make it more visible to the immune system, while immunotherapy helps sustain that response over time. Whether combination therapy makes sense for a specific patient is something a specialist team has to work out case by case. It's never really a default approach. 

Cancer Treatment Options in India: Where to Start 

For anyone newly diagnosed, the range of cancer treatment options in India can feel like a lot to take in. The starting point is almost always the same, though imaging, biopsy, and biomarker testing are followed by a conversation with an oncologist about what those results actually mean for treatment choice. IOCI runs this entire process through its International Tumour Board, where specialists across disciplines look at a case together before recommending chemotherapy, immunotherapy, or some combination of the two. Patients who've already started treatment elsewhere and want a fresh evaluation of their plan can also request a second opinion through IOCI. 

Conclusion 

The chemotherapy vs immunotherapy question isn't really about which drug is more powerful. It's about which one fits a particular cancer and a particular patient. Getting the answer right takes proper testing and a team willing to look closely at the details, rather than just defaulting to one option. If you're weighing treatment options, IOCI's oncology team can help you understand what your test results actually mean and which path makes sense for you.